Eledon Pharmaceuticals's total assets for Q2 2025 were $144.91M, a decrease of -10.17% from the previous quarter. ELDN total liabilities were $38.88M for the fiscal quarter, a -16.79% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.